Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
March 7, 2017
Patent Application Number
14861001
Date Filed
September 22, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
The antibodies enabled by the teaching of the present invention are particularly useful for the treatment of diseases and disorders which are caused by or associated with amyloid or amyloid-like proteins including amyloidosis, a group of diseases and disorders associated with amyloid plaque formation including secondary amyloidosis and age-related amyloidosis including, but not limited to, neurological disorders such as Alzheimer's Disease (AD).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.